Home
Home

Regeneron

Bayer/Regeneron Continue to Progress with Eylea

Bayer/Regeneron Continue to Progress with Eylea
Yahoo/Zacks.com

Sanofi-Regeneron drug tames eczema in study

Sanofi-Regeneron drug tames eczema in study
Yahoo/Reuters

Biotech Stock Roundup: Regado Plunges on Study Update, Jazz Gains on Product Acquisition Deal

Biotech Stock Roundup: Regado Plunges on Study Update, Jazz Gains on Product Acquisition Deal
Yahoo/Zacks.com

Sanofi raises stake in Regeneron to 22.5 percent from 20.5 percent

Sanofi raises stake in Regeneron to 22.5 percent from 20.5 percent
Reuters

Sanofi, Regeneron announce new data from positive sarilumab Phase 3 trial

Sanofi, Regeneron announce new data from positive sarilumab Phase 3 trial
The Fly on the Wall

Regeneron's Profit Soared 31% on Higher Collaboration Revenue and Eylea Sales

Regeneron's Profit Soared 31% on Higher Collaboration Revenue and Eylea Sales
Motley Fool

Monday’s Top Health Care Stories: Pfizer, Auxilium, and Regeneron

Monday’s Top Health Care Stories: Pfizer, Auxilium, and Regeneron
Motley Fool

Regeneron chief outranks every other biopharma CEO with $36M in 2013 pay

Regeneron chief outranks every other biopharma CEO with $36M in 2013 pay
Fierce Pharma

Novartis to Shire Said to Weigh Bids for ThromboGenics

Novartis to Shire Said to Weigh Bids for ThromboGenics
Bloomberg

Biotechs Struggling To Find A Bottom

Biotechs Struggling To Find A Bottom
Yahoo/Benzinga